SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors ramp up activity ahead of the upcoming Russell index reconstitution, fueling high expectations for passive institutional inflows. The community is actively discussing the stock's potential graduation to the Russell 1000, while closely monitoring for anticipated global partnership announcements in July that could act as a catalyst for a short squeeze.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following the announcement of a joint research agreement with Honda, which investors view as critical validation of its solid-state battery technology. The community is actively debating the significance of the news, with many pointing to the partnership as a major de-risking event that suggests growing commercial momentum and potential for additional OEM collaborations.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently facing significant downward pressure and technical breakdowns, leading to intense debate among community members over whether this represents a generational buying opportunity or a deeper valuation reset. Investors are closely monitoring key support levels as sentiment shifts, while discussion remains divided between those betting on the company's long-term AI-driven fundamental narrative and those cautioning against ongoing sector-wide multiple compression.

Roundhill ETF Trust - Roundhill Memory ETF

$DRAM is currently trending as investors focus on the memory sector's role as a critical bottleneck for AI infrastructure ahead of upcoming Micron earnings. The community remains highly active in debating whether the current price action reflects a structural re-rating of memory as an essential AI asset or a cyclical trend nearing an exhaustion point.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm, through its storage cloud platform, provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng and Brian Wilson in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is trending following a transformational five-year, $335 million storage partnership with CoreWeave that significantly boosts revenue visibility and highlights its role in AI infrastructure. Community sentiment remains polarized between bulls citing this major AI-linked contract as a long-term re-rating catalyst and bears expressing skepticism regarding debt levels and the potential for future share offerings.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning is trending due to its pivotal role in the AI data center supply chain, bolstered by a multi-billion-dollar fiber-optic partnership with Amazon that builds on existing deals with major hyperscalers. Investors and the community are actively debating the stock's long-term potential as an essential "picks and shovels" play, with technical traders closely monitoring its breakout momentum and high option volume.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is gaining momentum as investors anticipate the upcoming 80th event milestone for its Phase 3 REGAL trial, fueling intense speculation about a potential buyout from big pharma. Community sentiment remains highly charged, with intense debate over short interest levels, skyrocketing borrow fees, and the long-term potential of the GPS platform.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is experiencing significant volatility and scrutiny from the investor community as it nears its inaugural quarterly earnings report, with sentiment divided between enthusiasm for its AI inference partnerships with OpenAI and AWS and concerns over stretched valuations, heavy insider share lockup expirations, and competitive pressures.

Arqit Quantum, Inc. engages in the provision of cybersecurity services via satellite and terrestrial forms. Its product is QuantumCloud which secures devices with cloud-based quantum encryption. The company was founded by David John Williams and David James Bestwick on April 26, 2021 and is headquartered in London, the United Kingdom.

Arqit Quantum Inc

Arqit Quantum is generating significant buzz as a high-volatility short squeeze candidate, fueled by a tight float and recent White House executive orders prioritizing post-quantum cryptography. While the community is actively debating its speculative potential and contrasting its low valuation with other quantum-sector leaders, traders remain focused on whether price action can sustain momentum above key psychological thresholds.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing significant volatility and a sharp pullback as investors weigh contagion fears from the South Korean semiconductor sector against high expectations for the company's upcoming earnings release. The community remains deeply divided, with bulls viewing the dip as an attractive entry point driven by sustained AI-related memory demand, while bears argue the stock is in a parabolic blow-off phase ripe for a broader correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immunic to Participate in Investor, Industry and Scientific Conferences in June

Immunic to Participate in Investor, Industry and Scientific Conferences in June Immunic to Participate in Investor, Industry and Scientific Conferences in June PR Newswire NEW YORK, June 10, 2026 NEW YORK, June 10, 2026 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX),a late-stage biotechnology company...

Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis

Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026...

Immunic names Erik Lundgren as CEO as it advances Phase 3 MS trials

Immunic names Erik Lundgren as CEO as it advances Phase 3 MS trials...

Immunic Names Erik Lundgren Chief Executive Officer

(RTTNews) - Immunic, Inc. (IMUX), a late-stage biotechnology company, on Wednesday said it has appointed Erik Lundgren as its new chief executive officer, effective May 22, 2026, with employment set to begin on June 1...

Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer

Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer PR Newswire NEW YORK, May 27, 2026 Proven Leader with Deep Multiple Sclerosis Expertise; Played Key...

EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO

Immunic (IMUX) stock rises premarket to $13.14 as the company names former Genentech executive Erik Lundgren as CEO. See how his historic multiple sclerosis drug launch experience accelerates Immunic's Phase 3 trials in 2026.read more...

Immunic appoints Biogen, Cubist veteran Mike Bonney as board chair ahead of key MS trial readout

Immunic appoints Biogen, Cubist veteran Mike Bonney as board chair ahead of key MS trial readout...

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the...

Immunic (NASDAQ:IMUX) Upgraded by Lifesci Capital to "Strong-Buy" Rating

Lifesci Capital raised shares of Immunic to a "strong-buy" rating in a report on Monday...

HC Wainwright Estimates Immunic's Q1 Earnings (NASDAQ:IMUX)

Immunic, Inc. (NASDAQ:IMUX - Free Report) - Stock analysts at HC Wainwright raised their Q1 2026 earnings per share (EPS) estimates for Immunic in a report issued on Thursday, April 30th. HC Wainwright analyst M. Caufield now anticipates that the company will post earnings of ($0.20) per share for t...

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on multiple sclerosis, celiac disease and other neurologic and gastrointestinal disorders. The firm's products include IMU-838, IMU-856, and IMU-381. The company was founded in 2016 and is headquartered in New York, NY.

Immunic Inc

IMUX Stock Jumps 6% Pre-Market Today – Here’s The Latest Update On Its Compliance With Nasdaq Listing Rules 

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$1.18	--	--	N/A
Q1 '26	-$0.69	-$1.08	-57.09%	MISSED
Q4 '25	-$0.09	--	--	N/A
Q3 '25	-$0.14	-$0.13	9.30%	BEAT
Q2 '25	-$0.16	-$0.20	-26.74%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

IMUXImmunic Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest IMUX News